Fasenra Pen 30 mg/mL single-dose autoinjector Images
Generic Name: benralizumab
This medication has been identified as Fasenra Pen 30 mg/mL single-dose autoinjector. It is supplied by AstraZeneca.
Fasenra is used in the treatment of Eosinophilic Granulomatosis with Polyangiitis; Asthma and belongs to the drug class interleukin inhibitors. Fasenra 30 mg/mL single-dose autoinjector is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Fasenra Pen
- Generic Name
- benralizumab
- Strength
- 30 mg/mL single-dose autoinjector
- Availability
- Prescription only
- Drug Class
- Interleukin inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AstraZeneca
- National Drug Code (NDC)
- 00310-1830
See also:
Singulair
Singulair (montelukast) is used to prevent asthma attacks in adults and children as young as 12 ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Xolair
Xolair injection (omalizumab) is used to help improve allergic asthma, nasal polyps, and chronic ...
Ventolin HFA
Ventolin HFA (albuterol) is used to treat or prevent breathing problems in patients who have asthma ...
Ventolin
Ventolin is used for asthma, acute, asthma, maintenance, bronchiectasis, bronchospasm prophylaxis ...
Breo Ellipta
Breo Ellipta (fluticasone and vilanterol) is used to prevent airflow obstruction or bronchospasm in ...
Xopenex
Xopenex is a short-acting bronchodilator used to treat or prevent bronchospasm in asthma and other ...
Dulera
Dulera Inhalers (formoterol and mometasone) are used to treat asthma. Includes Dulera side effects ...
More about Fasenra (benralizumab)
- Check interactions
- Compare alternatives
- Reviews (76)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.